A co-therapeutic regimen comprising AAV9-mediated intrathecal/intracisternaland/or systemic delivery of anexpression cassette containing a hIDUA gene and two or more immunosuppressantsis provided herein. Also provided are methods useful fortreating hIDUA deficiency (MPSI) and the symptoms associated with Hurler,Hurler-Scheie and Scheie syndromes.